Our Opinion

Cogent Biosciences Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Company Description

Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. The Company’s most advanced program is CGT9486, a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation, as well as other mutations in KIT exon 17, to treat Systemic Mastocytosis (SM) and gastrointestinal stromal tumors (GIST).

Company Website: https://www.cogentbio.com